Plain-English translation of NCT07209176 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
This trial is testing whether simple reminders to doctors and educational handouts for patients can help more men with metastatic prostate cancer get genetic testing (called next-generation sequencing, or NGS). Genetic testing can help doctors understand your cancer better, predict how it might progress, and find treatments that may work best for you. The trial is designed to remove barriers that prevent patients from getting this important test.
Even though national medical guidelines recommend genetic testing for all men with metastatic prostate cancer, many patients don't receive it โ only about 50-60% at Johns Hopkins get tested. Research shows that older men and unmarried men are even less likely to get tested. This trial aims to fix that gap by helping doctors remember to order the test and making sure patients have clear information about why it matters.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you join this trial, your doctor will receive a reminder email about the importance of genetic testing, along with current medical guidelines. You will also receive a one-page educational handout (via email or mail) explaining what genetic testing is and why it matters for your care. The study runs through the end of 2026, and the main thing you'll do is be available for your regular medical oncology visits โ no extra procedures or medications are involved.
AI-generated summary from trial data ยท Jun 3, 2026 ยท Not medical advice
United States
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators
Pfizer
Enrollment target
~256 participants
Started
January 2026
Primary completion
September 2027
Age range
18 Years and older
Sex
Male only
Last updated on clinicaltrials.gov in February 2026.
Reach out to the team running this trial. Response times vary โ some teams are faster than others.
Central contact
Catherine Marshall, MD
Johns Hopkins University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first โ no email needed to get started.